Your browser doesn't support javascript.
loading
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus.
Kajihara, Akiko; Morita, Takayoshi; Kato, Yasuhiro; Konaka, Hachiro; Murakami, Teruaki; Yamaguchi, Yuta; Koyama, Shohei; Takamatsu, Hyota; Nishide, Masayuki; Maeda, Yuichi; Watanabe, Akane; Nishida, Sumiyuki; Hirano, Toru; Shima, Yoshihito; Narazaki, Masashi; Kumanogoh, Atsushi.
Affiliation
  • Kajihara A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Morita T; Laboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Kato Y; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Konaka H; Laboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Murakami T; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Yamaguchi Y; Laboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Koyama S; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Takamatsu H; Department of General Medicine, Nippon Life Hospital, Public Interest Incorporated Foundation, 2-1-54 Enokojima, Osaka Nishi-ku, Osaka 550-0006, Japan.
  • Nishide M; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Maeda Y; Laboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Watanabe A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Nishida S; Laboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Hirano T; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Shima Y; Laboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Narazaki M; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Kumanogoh A; Laboratory of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Int Immunol ; 35(1): 27-41, 2023 01 21.
Article in En | MEDLINE | ID: mdl-35997780
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukocytes, Mononuclear / Lupus Erythematosus, Systemic Type of study: Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukocytes, Mononuclear / Lupus Erythematosus, Systemic Type of study: Prognostic_studies Limits: Humans Language: En Year: 2023 Type: Article